Variables |
baseline |
4 months |
12 months |
P-value* |
|
ASD group |
VSD group |
Total |
p value |
ASD group |
VSD group |
Total |
p value |
ASD group |
VSD group |
Total |
p value |
|
FC |
3.2±0.45 |
3.6±0.55 |
3.4±0.52 |
0.242 |
2.8±0.45 |
3±0 |
2.9±0.32 |
0.347 |
2.8±0.45 |
2.8±0.45 |
2.8±0.42 |
1.0 |
0.16 |
6 minute walk distance (m) |
288.96±33.69 |
261.82±50.61 |
290.11±65.34 |
0.347 |
304.0±35.07 |
306.0±66.39 |
305±50.07 |
0.94 |
294.0±32.86 |
323.2±23.69 |
325.1±40.64 |
0.146 |
0.126 |
The Borg dyspnea index |
2.6±1.14 |
3.6±0.89 |
3.1±1.1 |
0.161 |
1.6±2.04 |
2.1±1.24 |
1.85±1.61 |
0.653 |
0.5±0.5 |
1.2±0.75 |
0.93±0.72 |
0.21 |
0.546 |
Hemoglobin (g/dl) |
16.36±1.77 |
18.78±1.49 |
17.57 + 2.00 |
0.51 |
16.44±1.50 |
18.90±1.42 |
17.67 + 1.89 |
0.6 |
15.92±1.60 |
19.92±0.71 |
17.92 + 2.41 |
0.06 |
0.726 |
NT-proBNP (pg/dl) |
924.4±112.5 |
537.00±733.69 |
731.70 + 918.98 |
0.53 |
537.0±864.93 |
442.0±448.02 |
599 + 670.19 |
0.49 |
391.8±348.15 |
446.0±690.18 |
418.90 ±516.14 |
0.879 |
0.497 |
AST (iU/L) |
24.6±7.36 |
24.8±7.25 |
24.7 + 6.89 |
0.96 |
24.6±7.26 |
22.8±6.3 |
23.70 + 6.48 |
0.68 |
22.2±2.77 |
26.4±7.73 |
37.00 + 5.90 |
0.28 |
0.910 |
ALT (iU/L) |
13.8±3.76 |
16.8±7.01 |
15.30 + 5.54 |
0.428 |
20.8±11.43 |
16.6±6.76 |
18.7 + 9.13 |
0.5 |
15.0±4.06 |
21±9.5 |
18.00 + 7.59 |
0.23 |
0.487 |
NT-pro BNP: N-terminal pro brain natriuretic peptide, AST: aspartate aminotransferance, ALT: alanine aminotransrerase, p-value* was among total group, p-value was
among subgroup, all were compared at baseline, 4 months and 12 months. |
